BioConnect — Your Life. Better.

Medications For Weight Loss

2 min read · Updated 15 April 2025

How does semaglutide help with weight loss?

Semaglutide mimics the natural hormone GLP-1 to reduce hunger, slow stomach emptying and increase feelings of fullness, helping people eat less. Ozempic and Wegovy both contain semaglutide, but Ozempic is cleared for diabetes while Wegovy is approved for weight loss. Treatment should be guided by a healthcare professional.

  • Semaglutide reduces appetite and slows stomach emptying.
  • Ozempic is cleared for diabetes; Wegovy is approved for weight loss.
  • These once-weekly injections require medical guidance and can cause digestive side effects.

Understanding Ozempic and Its Role as a Semaglutide for Weight Loss

Ozempic is a medication that has gained significant attention for its role in managing type 2 diabetes and promoting weight loss. While Ozempic has been cleared for diabetes, Wegovy, which is manufactured by the same pharmaceutical company, is approved for weight loss. Both are offered by BioConnect Medical Centre.

These medications contain the active ingredient semaglutide, which mimics the action of a natural hormone called GLP-1 (glucagon-like peptide-1). GLP-1 helps regulate blood sugar levels, slow gastric emptying, and suppress appetite, making them an effective tool for both glycemic control and weight management.

How Does Semaglutide Works?

  • Blood Sugar Regulation: Semaglutide enhances the body’s insulin response and reduces the amount of glucose produced by the liver, helping to maintain stable blood sugar levels.
  • Appetite Suppression: By mimicking GLP-1, semaglutide influences the brain’s appetite centers, leading to reduced hunger and lower calorie intake.
  • Slowed Gastric Emptying: The medication slows down the movement of food from the stomach to the intestines, increasing feelings of fullness and reducing overall food consumption.

Benefits of Semaglutide for Weight Loss

  • Effective Weight Reduction: Clinical trials have shown that individuals taking these medications can experience significant weight loss compared to those on placebo or other treatments.
  • Improved Metabolic Health beyond weight loss, semaglutide can improve various markers of metabolic health, including blood pressure and cholesterol levels.
  • Convenient Dosage: Administered once weekly via injection, these medications offers a convenient and manageable treatment regimen.

Considerations

While semaglutide is a powerful tool for weight loss, it is important to use it under the guidance of a healthcare professional. Potential side effects can include nausea, vomiting, and gastrointestinal discomfort, particularly when starting the treatment.

Through its active ingredient semaglutide, these medications offers a promising solution for individuals struggling with weight management, it addresses multiple facets of weight loss, contributing to overall health improvement. Consult with our Physician to determine if semaglutide is the right option for your weight loss journey.

For patients who do not respond to Ozempic or Wegovy, BioConnect also offers Mounjaro which uses tirzepatide, a dual GIP and GLP-1 receptor agonist, while Wegovy uses semaglutide, a GLP-1 receptor agonist.

Do You Have Any Questions?

Call us at +1(246)537-6328

How BioConnect can help

BioConnect offers Ozempic and Wegovy, with a physician to help you explore whether semaglutide is right for your weight management journey. Book a consultation with our team to discuss your options and any questions about treatment.

Why BioConnect: menopause specialists, members of the Menopause Society, and gynaecology, skin, weight and hormone care together under one roof in Barbados.

Book a consultation

Common questions

What side effects can semaglutide cause?

Potential side effects include nausea, vomiting and gastrointestinal discomfort, particularly when starting treatment.

How often are Ozempic and Wegovy administered?

Both medications are administered once weekly by injection.

Does BioConnect offer an alternative to Ozempic or Wegovy?

BioConnect also offers Mounjaro for patients who do not respond to Ozempic or Wegovy. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist, rather than semaglutide.

This article is general information and not a substitute for personal medical advice.

Keep reading

Need help? Call us

+1 (246) 537-6328

Find BioConnect

Our clinic is conveniently located 5 minutes away from Warrens and 15-20 minutes from the West or South Coast of Barbados.

Make an Appointment

Phone number is required so we can call you back.